New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 11, 2014
08:46 EDTHNSNHansen Medical announces FDA clearance of Magellan 6Fr Robotic Catheter
Hansen Medical announced it has received FDA clearance for its smaller diameter Magellan 6Fr Robotic Catheter for peripheral vascular interventions. The Magellan 6Fr Robotic Catheter is the latest addition to the growing family of catheters available for use with the Magellan Robotic System, and features several important advances. Specifically, the Magellan 6Fr Robotic Catheter features novel dual-bend technology, enabling independent robotic control of two separate bend sites on a single catheter, compared to the current Magellan 9Fr Robotic Catheter which is designed as a telescoping device with two, independently controlled robotic catheters. The 6Fr catheter's new design provides for precise robotic navigation and control in a single, smaller diameter 6Fr outer diameter catheter, and enables use of the Magellan Robotic System in smaller vessels in the peripheral vasculature and by physicians who may prefer a smaller diameter vessel insertion site.
News For HNSN From The Last 14 Days
Check below for free stories on HNSN the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 29, 2014
16:36 EDTHNSNHansen Medical announces publication of Uterine Artery Embolization results
Hansen Medical said a study, published online in the Journal of Vascular Interventional Radiology, found the use of the Magellan Robotic System in uterine artery embolization, or UAE, procedures is feasible and appears to be safe. All procedures were successfully completed without local puncture site complications or access vessel injuries. Further, robotic bilateral internal iliac artery cannulation was successfully performed in all cases. At the six-month follow-up mark, all patients reported significant improvement in symptoms and quality-of-life.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use